§ Dr. StrangTo ask the Chancellor of the Duchy of Lancaster if he will make a statement on the EC-approved network of co-operation agreements between the Imperial Cancer Research Fund, the Medical Research Council, University College, London, and the United States research foundation Southwest, for research and development of a vaccine to combat HIV infections.
§ Mr. WaldegraveThe Medical Research Council, University College, London, the Imperial Cancer Research Fund and the Southwest Foundation for Biomedical Research are all shareholders of HIVER Limited which is a research driven healthcare company located in the United Kingdom. HIVER Limited focuses on developing vaccines, therapies and diagnostics for AIDS and other immunological disorders.
Since 1987, more than £4 million has been committed to the research programme. Research is currently underway at The MRC clinical research centre, University College London, The London hospital medical school and St. Georges hospital medical school. The research is coordinated from the HIVER executive office.